From Name:
From Email:
To Name:
To Email:

Optional Message:


In-hospital Mortality Hasn't Budged Despite Changes in MCS for Cardiogenic Shock

from TCTMD

That newer forms of mechanical circulatory support are on the rise and intra-aortic balloon pump therapy is on the decline won’t come as a surprise to anyone watching trends in cardiogenic shock care. Less intuitively, though, the mortality rate has stayed stubbornly high despite these shifts, according to an analysis of U.S. data on more than 400,000 patients treated between 2012 and 2015. “Despite significant advances in cardiovascular medicine, mortality from cardiogenic shock is still approximately 40% to 50%,” said Ankur Kalra, MD (Cleveland Clinic, OH), when presenting the results at TCT 2019. Kalra stressed that cardiogenic shock patients are a heterogeneous group. “Cardiogenic shock exists along the spectrum of severity, and it’s difficult to establish a one-size-fits-all treatment,” he said. This is why the recent attempt by the for Cardiovascular Angiography and Interventions to standardize the “verbiage of how we define shock” is so important, Kalra noted. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063